Novel Albicidin Derivatives, Their Use and Synthesis

Simple SummaryContent extracted from patent full text and abstract with AI.

This invention relates to novel derivatives of albicidin, a natural peptide-derived compound known for its strong antibacterial activity as a DNA-gyrase inhibitor. The patent discloses new chemical modifications of the albicidin molecule, methods to synthesize these derivatives, and demonstrates their enhanced or diversified antibacterial properties through extensive biological testing. These new albicidin derivatives show promising activity against a range of Gram-positive and Gram-negative bacteria, including strains with relevant clinical resistance.

Use CasesContent extracted from patent full text and abstract with AI.

• Treatment of bacterial infections, including those caused by antibiotic-resistant strains
• Development of new broad-spectrum antibiotics for human health
• Use in veterinary medicine to treat bacterial diseases in livestock and pets
• Incorporation into topical formulations or wound dressings to prevent/treat infections
• Use as antibacterial agents in plant agriculture to control pathogenic bacteria
• Inclusion in sanitizing or disinfection products where strong antibacterial efficacy is needed
• Development of diagnostic platforms by leveraging activity against specific bacterial enzymes such as DNA-gyrase

BenefitsContent extracted from patent full text and abstract with AI.

• Potential to combat antibiotic resistance due to novel mode of action and activity against resistant bacteria
• Greater structural diversity enables tuning for specific pharmacological properties (e.g., potency, selectivity, safety)
• Broad-spectrum antibacterial activity (effective against both Gram-positive and Gram-negative bacteria)
• Possibility to formulate for different routes of administration (oral, injectable, topical, etc.)
• Provides new chemical scaffolds for further development of antibiotics or diagnostic tools
• Synthetically accessible compounds can be produced at scale
• Option to develop tailor-made prodrugs and formulations for improved bioavailability and patient compliance

Technical Classifications (CPCs)

Inventors & Applicants

Patent Abstract

The present invention relates to a chemical compound according to general formula (1).